Superiority, equivalence and non-inferiority

Quality Progress

Volumn 40, Issue 2, 2007, Pages 52-54

  Allen, I Elaine ^a,b   Seaman, Christopher A ^c  

^a BABSON COLLEGE   (United States)

^b ASQ ^*

^c CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33847740323     PISSN: 0033524X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (4)

1. D'Agostino, R.B., J.M. Massaro and L.M. Sullivan, "Non-inferiority Trials: Design Concepts and Issues-The Encounters of Academic Consultants in Statistic," Statistics in Medicine, Vol. 22, No. 2, 2003, pp. 169-186.
2. European Medicines Agency, "Points to Consider on Switching Between Superiority and Non-inferiority," www.emea.europa.eu, 2000.
3. Morikawa T., and M. Yoshida, "A Useful Testing Strategy in Phase III Trials: Combined Test of Superiority and Test of Equivalence," J Biopharm Stat, Vol. 5, 1995, pp. 297-306.
4. Pater, Cornel, "Equivalence and Noninferiority Trials - Are They Viable Alternatives for the Registration of New Drugs?" Business Briefing: Pharmagenerics, 2004, pp. 50-55.